Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667663 | SCV000792149 | pathogenic | Alstrom syndrome | 2017-06-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000667663 | SCV002240759 | pathogenic | Alstrom syndrome | 2024-01-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg3611Alafs*6) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is present in population databases (rs755616266, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with clinical features of Alström syndrome (PMID: 17594715, 26010121, 29720996). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 552413). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000667663 | SCV002802386 | pathogenic | Alstrom syndrome | 2021-11-10 | criteria provided, single submitter | clinical testing | |
Department of Pediatrics, |
RCV000667663 | SCV004046850 | pathogenic | Alstrom syndrome | no assertion criteria provided | clinical testing |